Get the Stockscreener App
83.20
3.05%
2.3964
Solventum Corp stock is traded at $83.20, with a volume of 698.83K.
It is up +3.05% in the last 24 hours and down -2.54% over the past month.
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
See More
Previous Close:
$80.80
Open:
$80.78
24h Volume:
698.83K
Relative Volume:
0.68
Market Cap:
$14.42B
Revenue:
$8.31B
Net Income/Loss:
$379.00M
P/E Ratio:
38.52
EPS:
2.16
Net Cash Flow:
$385.00M
1W Performance:
+3.87%
1M Performance:
-2.54%
6M Performance:
+6.07%
1Y Performance:
+21.61%
1-Day Range:
$80.66
$83.36
1-Week Range:
$78.18
$83.36
52-Week Range:
$60.70
$88.20
Solventum Corp Stock (SOLV) Company Profile
Name
Solventum Corp
Sector
Industry
Phone
651-733-1110
Address
C/O 3M COMPANY, ST. PAUL
Compare SOLV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
83.14 | 14.01B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
592.50 | 200.78B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
205.51 | 56.69B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
81.76 | 39.62B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
249.21 | 35.81B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
39.77 | 30.70B | 27.43B | 1.27B | 1.01B | 1.5829 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Sep-11-25 | Initiated | Jefferies | Hold |
| Jul-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-01-25 | Upgrade | Argus | Hold → Buy |
| Jun-06-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-19-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Oct-08-24 | Initiated | Stifel | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Neutral |
| Sep-26-24 | Initiated | Wolfe Research | Peer Perform |
| Sep-05-24 | Initiated | BTIG Research | Neutral |
| Jun-24-24 | Initiated | Argus | Hold |
| May-30-24 | Initiated | Goldman | Sell |
| May-10-24 | Initiated | BofA Securities | Neutral |
| Apr-10-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-08-24 | Initiated | Wells Fargo | Equal Weight |
| Apr-02-24 | Initiated | Edward Jones | Hold |
View All
Solventum Corp Stock (SOLV) Latest News
Solventum Advances Orthodontic Treatment by Helping Shape Modern Orthodontics - Digital Journal
Bioprocess Filtration Global Markets Report 2025-2030, Profiles of Leading PlayersDanaher, Merck, Sartorius, Solventum, and RepligenResearchAndMarkets.com - FinancialContent
Solventum Corp. stock falls Wednesday, underperforms market - MarketWatch
Solventum to Acquire Acera Surgical in $725 Mn Deal to Boost Regenerative Wound-Care Portfolio - Digital Health News
Key sale, acquisition helped 3M spinoff, Solventum, turn around in 2025 - Star Tribune
Are Medical Stocks Lagging Solventum Corporation (SOLV) This Year? - Yahoo Finance
Harbor Capital Advisors Inc. Has $1.31 Million Stake in Solventum Corporation $SOLV - MarketBeat
Solventum Corporation (NYSE:SOLV) Given Consensus Rating of "Hold" by Analysts - MarketBeat
SOLV Acquires Acera Surgical to Expand Advanced Wound Care Portfolio - sharewise.com
Strong Tower Advisory Services Buys 16,851 Shares of Solventum Corporation $SOLV - MarketBeat
Solventum Completes Acquisition of Acera Surgical - The Malaysian Reserve
Solventum completes acquisition of Acera Surgical for $725 million By Investing.com - Investing.com Nigeria
Solventum Closes Acquisition of Acera Surgical - marketscreener.com
Solventum completes Acera Surgical acquisition - MassDevice
Solventum completes acquisition of Acera Surgical for $725 million - Investing.com India
Solventum is the top performing healthcare supplies stock YTD - MSN
Solventum is the top performing healthcare supplies stock YTD (SOLV:NYSE) - Seeking Alpha
Is Solventum stock outperforming the Nasdaq? - MSN
How Investors Are Reacting To Solventum (SOLV) Expert Guidance Expanding Use Of Prevena ciNPT Dressings - simplywall.st
Wedge Capital Management L L P NC Sells 64,461 Shares of Solventum Corporation $SOLV - MarketBeat
Will Expert Backing for ciNPT Prevena Dressings Redefine Solventum's (SOLV) Advanced Wound Care Edge? - Yahoo Finance
Why retail investors pile into Solventum Corporation stock2025 Top Decliners & Stepwise Swing Trade Plans - Улправда
Is Solventum Stock Underperforming the S&P 500? - MSN
Solventum (SOLV): Assessing Valuation After New Clinical Guidance Expands Prevena Therapy’s Surgical Use - simplywall.st
Argus Research Adjusts Solventum Price Target to $100 From $90, Maintains Buy Rating - marketscreener.com
Assenagon Asset Management S.A. Boosts Position in Solventum Corporation $SOLV - MarketBeat
Global Expert Panel Publishes New Recommendations on Advanced Use of Closed Incision Negative Pressure Therapy - Finviz
New surgery guidelines expand use of vacuum dressings to protect incisions - Stock Titan
Piper Sandler names Solventum stock its 2026 top idea, maintains $98 target - Investing.com Nigeria
Solventum Corporation reflects on transformative year - MSN
Solventum Earns Diamond Level HIRC Resiliency Badge, Demonstrating Best-In-Class Supply Chain Strength - Finviz
Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch
Solventum earns diamond level supply chain certification for healthcare By Investing.com - Investing.com Australia
Solventum earns diamond level supply chain certification for healthcare - Investing.com
3M at a Crossroads: Strategic Moves and Persistent Headwinds - AD HOC NEWS
Solventum Corporation Reflects on Transformative Year - TipRanks
Wells Fargo Adjusts Price Target on Solventum to $86 From $72, Maintains Equalweight Rating - marketscreener.com
Solventum Corp Reflects on Year of Growth and Transformation - TradingView — Track All Markets
Is Solventum Stock Outperforming the Nasdaq? - Yahoo Finance
Solventum Corp Stock (SOLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Solventum Corp Stock (SOLV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| 3M CO | 10% Owner |
Aug 15 '25 |
Sale |
73.45 |
8,800,000 |
646,360,000 |
25,569,190 |
| COX CARRIE SMITH | Director |
May 13 '25 |
Option Exercise |
0.00 |
5,148 |
0 |
5,148 |
| Hanson Bryan C | Chief Executive Officer |
May 13 '25 |
Option Exercise |
0.00 |
34,315 |
0 |
75,108 |
| Harris Bernard A Jr | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Edwards Shirley Ann | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Wilcox Mary T | Chief Accounting Officer |
May 13 '25 |
Option Exercise |
0.00 |
2,375 |
0 |
2,375 |
| DeVore Susan D. | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| ALBAN CARLOS | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Harrington Paul S | Chief Supply Chain Officer |
May 13 '25 |
Option Exercise |
0.00 |
3,959 |
0 |
11,220 |
| Wendell Amy McBride | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
1.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):